Ashkan Shoamanesh: Should Intracranial Hemorrhage Survivors with AFib Receive Anticoagulation?
Ashkan Shoamanesh, Associate Professor of Medicine (Neurology), Marta and Owen Boris Chair in Stroke Research and Care at McMaster University, shared on LinkedIn:
”Should intracranial hemorrhage (ICrH) survivors with atrial fibrillation receive anticoagulation?
If so: under which clinical circumstances?, after what time interval?, with what strategies to mitigate ICrH recurrence risk? and what is the level of supporting evidence?
These are common yet challenging questions in stroke practice, with many remaining unresolved.
We address them in detail in our recently published comprehensive review in the European Stroke Organisation Journal.”
Read the full article here.
Article: Oral Anticoagulation following intracranial haemorrhage in patients with atrial fibrillation
Authors: Ashkan Shoamanesh, Catharina JM Klijn, Kevin N Sheth, Roland Veltkamp, Else C Sandset, Charlotte Cordonnier, Rustam Al-Shahi Salman
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 16, 2026, 06:05Wolfgang Miesbach on Jacob Lund’s Study: How to Define FVIII Bioequivalence
-
Jan 16, 2026, 05:52Piotr Czempik Shares His Latest Contribution to Acta Haematologica Polonic
-
Jan 16, 2026, 05:44Florian Piekarski on Perioperative Blood Management When Allogeneic Transfusion is Not Aaccepted
-
Jan 16, 2026, 05:00Plaque Rupture and Thrombosis
-
Jan 16, 2026, 04:52Arterial Disease Across Vascular Beds․ Lipoprotein(a) as a Causal Risk Factor
-
Jan 16, 2026, 04:51Higher-Dose Clotting Factor Prophylaxis Does Not Reduce Postpartum Hemorrhage in Women with von Willebrand Disease
-
Jan 16, 2026, 04:48Reza Shojaei on Plasma Donation as Life-Changing Medicine in Motion
-
Jan 16, 2026, 04:11Open-Label Extension Study of Marstacimab: Pfizer Has Reported a Fatal Event
-
Jan 16, 2026, 04:11Why is DVT More Common In the Left Leg? Dr Raheel Moazzam’s New Study Gives Answers!